Chronic Coronary Artery Disease: New Treatments and Future Directions
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".
Deadline for manuscript submissions: 12 March 2025 | Viewed by 38
Special Issue Editor
Interests: clinical cardiology; emergency medicine; public health; statistics
Special Issue Information
Dear Colleagues,
Coronary artery disease (CAD) is a critical health challenge that affects both people and healthcare systems. CAD leads to arterial narrowing and obstruction, resulting in severe problems such as heart attacks and heart failure. Collaborative efforts by researchers, professionals, and governments have generated discussions regarding the control and management of this cardiovascular state. The evolution of CAD management encompasses contemporary diagnostics, cutting-edge medications, invasive treatments, lifestyle adjustments, and cardiac rehabilitation. This comprehensive approach strives to amplify outcomes and enhance the quality of life for patients affected by CAD.
This Special Issue of the Journal of Clinical Medicine will address the following:
- Diagnostic technologies enabling early detection and risk assessment.
- Recent advancements in drugs that drastically ameliorate platelet disorders, lipid reduction, and angina.
- Advances in invasive treatments, notably percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
- The significance of lifestyle changes and cardiac rehabilitation in CAD management.
- Therapeutic options and patient recovery and rehabilitation.
- Medications and supplements.
- Recent advancements in lipids modifications – Lp(α).
- Smoking, second-hand smoke and the cessation of e-cigarettes.
- Hormone Replacement Therapy (HRT).
- Research on the design of new avenues in CAD therapy, from breakthrough medications to collaborative multidisciplinary care paradigms.
In this review, novel medicines, significant breakthroughs, and contemporary developments in clinical practices that collectively influence CAD care are discussed.
Dr. Ioannis Vogiatzis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- risk assessment
- coronary atherosclerosis
- platelet disorders
- lipid reduction
- angina
- percutaneous coronary intervention (PCI)
- coronary artery bypass grafting (CABG)
- patient recovery and rehabilitation
- smoking, second-hand smoke and e-cigarettes cessation
